Top Markets
Coin of the day
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMO
Rangering i aksjer #78
Thermo Fisher Scientific Inc. is a global leader in scientific services,... Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Aksjekurs
$607.17
Sist synkronisert: 2026-09-09
Markedsverdi
$225.64B
Endring (1 dag)
0.53%
Endring (1 år)
27.41%
Land
US
Handel Thermo Fisher Scientific Inc. (TMO)

Kategori

P/E-forhold for Thermo Fisher Scientific Inc. (TMO)
P/E-forhold per September 2026 TTM: 33.14
Ifølge Thermo Fisher Scientific Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 33.14. Ved slutten av 2024 hadde selskapet en P/E på 31.37.
P/E-forholdshistorikk for Thermo Fisher Scientific Inc. fra 2000 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
2026 (TTM) 33.14 2.48%
2025 32.34 3.09%
2024 31.37 -8.21%
2023 34.18 10.03%
2022 31.06 -8.73%
2021 34.03 17.62%
2020 28.93 -17.71%
2019 35.16 14.82%
2018 30.62 -9.16%
2017 33.71 22.34%
2016 27.55 -3.76%
2015 28.63 8.71%
2014 26.34 -16.42%
2013 31.51 59.95%
2012 19.70 52.98%
2011 12.88 -40.27%
2010 21.56 -6.79%
2009 23.13 61.40%
2008 14.33 -55.14%
2007 31.94 -39.24%
2006 52.57 141.04%
2005 21.81 60.24%
2004 13.61 -33.61%
2003 20.50 88.61%
2002 10.87 -100.20%
2001 -5.50K 4,633.22%
2000 -116.27 0.00%
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
37.80 14.05%
US
- -
CN
-236.74 -814.31%
US
32.13 -3.06%
US
30.18 -8.93%
US
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.